+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Probiotic Supplements Market in Canada 2024-2028

  • PDF Icon

    Report

  • 147 Pages
  • December 2023
  • Region: Canada
  • TechNavio
  • ID: 5596133
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The probiotic supplements market in Canada is forecasted to grow by USD 75.75 mn during 2023-2028, accelerating at a CAGR of 6.33% during the forecast period. The report on the probiotic supplements market in Canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased awareness about lifestyle-related diseases, rising awareness and benefits of probiotic supplements, and increasing prevalence of digestive problems.

The probiotic supplements market in Canada is segmented as below:

By Disease Type

  • Gastrointestinal diseases
  • Infectious diseases
  • Others

By Type

  • Bacteria
  • Yeast

By End-user

  • Human probiotics
  • Animal probiotics
This study identifies the intensive research and development in probiotic supplements as one of the prime reasons driving the probiotic supplements market in Canada growth during the next few years. Also, rise in demand for weight management products and availability of probiotic supplements in online stores will lead to sizable demand in the market.

The report on the probiotic supplements market in Canada covers the following areas:

  • Probiotic supplements market in Canada sizing
  • Probiotic supplements market in Canada forecast
  • Probiotic supplements market in Canada industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading probiotic supplements market in Canada vendors that include American Biologics LLC, Archer Daniels Midland Co., Biena Inc., BioGaia AB, Biotix Care, Church and Dwight Co. Inc., CUSTOM PROBIOTICS Inc., Genuine Health Inc., International Flavors and Fragrances Inc., Jamieson Wellness Inc., Koninklijke DSM NV, Lallemand Inc., Mars Inc., Natural Factors Nutritional Products Ltd., NOVA Essentials Inc., PetLab Co., Reckitt Benckiser Group Plc, The Clorox Co., The Procter and Gamble Co., and Kerry Group Plc. Also, the probiotic supplements market in Canada analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Country Market Characteristics
Exhibit 04: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 08: Parent market
Exhibit 09: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 10: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 11: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 12: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 13: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 14: Chart on Canada: Year-over-year growth 2023-2028 (%)
Exhibit 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Probiotic supplements market in Canada 2018 - 2022
Exhibit 16: Historic Market Size - Data Table on probiotic supplements market in Canada 2018 - 2022 ($ million)
4.2 Disease Type Segment Analysis 2018 - 2022
Exhibit 17: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
4.3 Type Segment Analysis 2018 - 2022
Exhibit 18: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 20: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Disease Type
6.1 Market segments
Exhibit 27: Chart on Disease Type - Market share 2023-2028 (%)
Exhibit 28: Data Table on Disease Type - Market share 2023-2028 (%)
6.2 Comparison by Disease Type
Exhibit 29: Chart on Comparison by Disease Type
Exhibit 30: Data Table on Comparison by Disease Type
6.3 Gastrointestinal diseases - Market size and forecast 2023-2028
Exhibit 31: Chart on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
Exhibit 32: Data Table on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
Exhibit 33: Chart on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
Exhibit 34: Data Table on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
6.4 Infectious diseases - Market size and forecast 2023-2028
Exhibit 35: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
Exhibit 37: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibit 38: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 39: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibit 41: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 42: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Disease Type
Exhibit 43: Market opportunity by Disease Type ($ million)
Exhibit 44: Data Table on Market opportunity by Disease Type ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 45: Chart on Type - Market share 2023-2028 (%)
Exhibit 46: Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Exhibit 47: Chart on Comparison by Type
Exhibit 48: Data Table on Comparison by Type
7.3 Bacteria - Market size and forecast 2023-2028
Exhibit 49: Chart on Bacteria - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Data Table on Bacteria - Market size and forecast 2023-2028 ($ million)
Exhibit 51: Chart on Bacteria - Year-over-year growth 2023-2028 (%)
Exhibit 52: Data Table on Bacteria - Year-over-year growth 2023-2028 (%)
7.4 Yeast - Market size and forecast 2023-2028
Exhibit 53: Chart on Yeast - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Data Table on Yeast - Market size and forecast 2023-2028 ($ million)
Exhibit 55: Chart on Yeast - Year-over-year growth 2023-2028 (%)
Exhibit 56: Data Table on Yeast - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Type
Exhibit 57: Market opportunity by Type ($ million)
Exhibit 58: Data Table on Market opportunity by Type ($ million)
8 Market Segmentation by End-user
8.1 Market segments
Exhibit 59: Chart on End-user - Market share 2023-2028 (%)
Exhibit 60: Data Table on End-user - Market share 2023-2028 (%)
8.2 Comparison by End-user
Exhibit 61: Chart on Comparison by End-user
Exhibit 62: Data Table on Comparison by End-user
8.3 Human probiotics - Market size and forecast 2023-2028
Exhibit 63: Chart on Human probiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%)
8.4 Animal probiotics - Market size and forecast 2023-2028
Exhibit 67: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%)
8.5 Market opportunity by End-user
Exhibit 71: Market opportunity by End-user ($ million)
Exhibit 72: Data Table on Market opportunity by End-user ($ million)
9 Customer Landscape
9.1 Customer landscape overview
Exhibit 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 74: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 75: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 76: Overview on factors of disruption
11.4 Industry risks
Exhibit 77: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 78: Vendors covered
12.2 Market positioning of vendors
Exhibit 79: Matrix on vendor position and classification
12.3 American Biologics LLC
Exhibit 80: American Biologics LLC - Overview
Exhibit 81: American Biologics LLC - Product / Service
Exhibit 82: American Biologics LLC - Key offerings
12.4 Archer Daniels Midland Co.
Exhibit 83: Archer Daniels Midland Co. - Overview
Exhibit 84: Archer Daniels Midland Co. - Business segments
Exhibit 85: Archer Daniels Midland Co. - Key offerings
Exhibit 86: Archer Daniels Midland Co. - Segment focus
12.5 Biena Inc.
Exhibit 87: Biena Inc. - Overview
Exhibit 88: Biena Inc. - Product / Service
Exhibit 89: Biena Inc. - Key offerings
12.6 BioGaia AB
Exhibit 90: BioGaia AB - Overview
Exhibit 91: BioGaia AB - Business segments
Exhibit 92: BioGaia AB - Key news
Exhibit 93: BioGaia AB - Key offerings
Exhibit 94: BioGaia AB - Segment focus
12.7 Biotix Care
Exhibit 95: Biotix Care - Overview
Exhibit 96: Biotix Care - Product / Service
Exhibit 97: Biotix Care - Key offerings
12.8 Church and Dwight Co. Inc.
Exhibit 98: Church and Dwight Co. Inc. - Overview
Exhibit 99: Church and Dwight Co. Inc. - Business segments
Exhibit 100: Church and Dwight Co. Inc. - Key offerings
Exhibit 101: Church and Dwight Co. Inc. - Segment focus
12.9 Genuine Health Inc.
Exhibit 102: Genuine Health Inc. - Overview
Exhibit 103: Genuine Health Inc. - Product / Service
Exhibit 104: Genuine Health Inc. - Key offerings
12.10 International Flavors and Fragrances Inc.
Exhibit 105: International Flavors and Fragrances Inc. - Overview
Exhibit 106: International Flavors and Fragrances Inc. - Business segments
Exhibit 107: International Flavors and Fragrances Inc. - Key news
Exhibit 108: International Flavors and Fragrances Inc. - Key offerings
Exhibit 109: International Flavors and Fragrances Inc. - Segment focus
12.11 Jamieson Wellness Inc.
Exhibit 110: Jamieson Wellness Inc. - Overview
Exhibit 111: Jamieson Wellness Inc. - Business segments
Exhibit 112: Jamieson Wellness Inc. - Key news
Exhibit 113: Jamieson Wellness Inc. - Key offerings
Exhibit 114: Jamieson Wellness Inc. - Segment focus
12.12 Kerry Group Plc
Exhibit 115: Kerry Group Plc - Overview
Exhibit 116: Kerry Group Plc - Business segments
Exhibit 117: Kerry Group Plc - Key news
Exhibit 118: Kerry Group Plc - Key offerings
Exhibit 119: Kerry Group Plc - Segment focus
12.13 Koninklijke DSM NV
Exhibit 120: Koninklijke DSM NV - Overview
Exhibit 121: Koninklijke DSM NV - Business segments
Exhibit 122: Koninklijke DSM NV - Key news
Exhibit 123: Koninklijke DSM NV - Key offerings
Exhibit 124: Koninklijke DSM NV - Segment focus
12.14 Lallemand Inc.
Exhibit 125: Lallemand Inc. - Overview
Exhibit 126: Lallemand Inc. - Product / Service
Exhibit 127: Lallemand Inc. - Key offerings
12.15 Natural Factors Nutritional Products Ltd.
Exhibit 128: Natural Factors Nutritional Products Ltd. - Overview
Exhibit 129: Natural Factors Nutritional Products Ltd. - Product / Service
Exhibit 130: Natural Factors Nutritional Products Ltd. - Key offerings
12.16 NOVA Essentials Inc.
Exhibit 131: NOVA Essentials Inc. - Overview
Exhibit 132: NOVA Essentials Inc. - Product / Service
Exhibit 133: NOVA Essentials Inc. - Key offerings
12.17 Reckitt Benckiser Group Plc
Exhibit 134: Reckitt Benckiser Group Plc - Overview
Exhibit 135: Reckitt Benckiser Group Plc - Business segments
Exhibit 136: Reckitt Benckiser Group Plc - Key offerings
Exhibit 137: Reckitt Benckiser Group Plc - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 138: Inclusions checklist
Exhibit 139: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 140: Currency conversion rates for US$
13.4 Research methodology
Exhibit 141: Research methodology
Exhibit 142: Validation techniques employed for market sizing
Exhibit 143: Information sources
13.5 List of abbreviations
Exhibit 144: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Vendor Market Positioning
Exhibits 8: Parent market
Exhibits 9: Market Characteristics
Exhibits 10: Offerings of vendors included in the market definition
Exhibits 11: Market segments
Exhibits 12: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 13: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits 14: Chart on Canada: Year-over-year growth 2023-2028 (%)
Exhibits 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
Exhibits 16: Historic Market Size - Data Table on probiotic supplements market in Canada 2018 - 2022 ($ million)
Exhibits 17: Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
Exhibits 18: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 20: Five forces analysis - Comparison between 2023 and 2028
Exhibits 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 23: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 24: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 25: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 26: Chart on Market condition - Five forces 2023 and 2028
Exhibits 27: Chart on Disease Type - Market share 2023-2028 (%)
Exhibits 28: Data Table on Disease Type - Market share 2023-2028 (%)
Exhibits 29: Chart on Comparison by Disease Type
Exhibits 30: Data Table on Comparison by Disease Type
Exhibits 31: Chart on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 32: Data Table on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 33: Chart on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
Exhibits 34: Data Table on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
Exhibits 35: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 36: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits 38: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)
Exhibits 39: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 40: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 42: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 43: Market opportunity by Disease Type ($ million)
Exhibits 44: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 45: Chart on Type - Market share 2023-2028 (%)
Exhibits 46: Data Table on Type - Market share 2023-2028 (%)
Exhibits 47: Chart on Comparison by Type
Exhibits 48: Data Table on Comparison by Type
Exhibits 49: Chart on Bacteria - Market size and forecast 2023-2028 ($ million)
Exhibits 50: Data Table on Bacteria - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Chart on Bacteria - Year-over-year growth 2023-2028 (%)
Exhibits 52: Data Table on Bacteria - Year-over-year growth 2023-2028 (%)
Exhibits 53: Chart on Yeast - Market size and forecast 2023-2028 ($ million)
Exhibits 54: Data Table on Yeast - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Chart on Yeast - Year-over-year growth 2023-2028 (%)
Exhibits 56: Data Table on Yeast - Year-over-year growth 2023-2028 (%)
Exhibits 57: Market opportunity by Type ($ million)
Exhibits 58: Data Table on Market opportunity by Type ($ million)
Exhibits 59: Chart on End-user - Market share 2023-2028 (%)
Exhibits 60: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 61: Chart on Comparison by End-user
Exhibits 62: Data Table on Comparison by End-user
Exhibits 63: Chart on Human probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 65: Chart on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 68: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ million)
Exhibits 69: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%)
Exhibits 71: Market opportunity by End-user ($ million)
Exhibits 72: Data Table on Market opportunity by End-user ($ million)
Exhibits 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 74: Impact of drivers and challenges in 2023 and 2028
Exhibits 75: Overview on Criticality of inputs and Factors of differentiation
Exhibits 76: Overview on factors of disruption
Exhibits 77: Impact of key risks on business
Exhibits 78: Vendors covered
Exhibits 79: Matrix on vendor position and classification
Exhibits 80: American Biologics LLC - Overview
Exhibits 81: American Biologics LLC - Product / Service
Exhibits 82: American Biologics LLC - Key offerings
Exhibits 83: Archer Daniels Midland Co. - Overview
Exhibits 84: Archer Daniels Midland Co. - Business segments
Exhibits 85: Archer Daniels Midland Co. - Key offerings
Exhibits 86: Archer Daniels Midland Co. - Segment focus
Exhibits 87: Biena Inc. - Overview
Exhibits 88: Biena Inc. - Product / Service
Exhibits 89: Biena Inc. - Key offerings
Exhibits 90: BioGaia AB - Overview
Exhibits 91: BioGaia AB - Business segments
Exhibits 92: BioGaia AB - Key news
Exhibits 93: BioGaia AB - Key offerings
Exhibits 94: BioGaia AB - Segment focus
Exhibits 95: Biotix Care - Overview
Exhibits 96: Biotix Care - Product / Service
Exhibits 97: Biotix Care - Key offerings
Exhibits 98: Church and Dwight Co. Inc. - Overview
Exhibits 99: Church and Dwight Co. Inc. - Business segments
Exhibits 100: Church and Dwight Co. Inc. - Key offerings
Exhibits 101: Church and Dwight Co. Inc. - Segment focus
Exhibits 102: Genuine Health Inc. - Overview
Exhibits 103: Genuine Health Inc. - Product / Service
Exhibits 104: Genuine Health Inc. - Key offerings
Exhibits 105: International Flavors and Fragrances Inc. - Overview
Exhibits 106: International Flavors and Fragrances Inc. - Business segments
Exhibits 107: International Flavors and Fragrances Inc. - Key news
Exhibits 108: International Flavors and Fragrances Inc. - Key offerings
Exhibits 109: International Flavors and Fragrances Inc. - Segment focus
Exhibits 110: Jamieson Wellness Inc. - Overview
Exhibits 111: Jamieson Wellness Inc. - Business segments
Exhibits 112: Jamieson Wellness Inc. - Key news
Exhibits 113: Jamieson Wellness Inc. - Key offerings
Exhibits 114: Jamieson Wellness Inc. - Segment focus
Exhibits 115: Kerry Group Plc - Overview
Exhibits 116: Kerry Group Plc - Business segments
Exhibits 117: Kerry Group Plc - Key news
Exhibits 118: Kerry Group Plc - Key offerings
Exhibits 119: Kerry Group Plc - Segment focus
Exhibits 120: Koninklijke DSM NV - Overview
Exhibits 121: Koninklijke DSM NV - Business segments
Exhibits 122: Koninklijke DSM NV - Key news
Exhibits 123: Koninklijke DSM NV - Key offerings
Exhibits 124: Koninklijke DSM NV - Segment focus
Exhibits 125: Lallemand Inc. - Overview
Exhibits 126: Lallemand Inc. - Product / Service
Exhibits 127: Lallemand Inc. - Key offerings
Exhibits 128: Natural Factors Nutritional Products Ltd. - Overview
Exhibits 129: Natural Factors Nutritional Products Ltd. - Product / Service
Exhibits 130: Natural Factors Nutritional Products Ltd. - Key offerings
Exhibits 131: NOVA Essentials Inc. - Overview
Exhibits 132: NOVA Essentials Inc. - Product / Service
Exhibits 133: NOVA Essentials Inc. - Key offerings
Exhibits 134: Reckitt Benckiser Group Plc - Overview
Exhibits 135: Reckitt Benckiser Group Plc - Business segments
Exhibits 136: Reckitt Benckiser Group Plc - Key offerings
Exhibits 137: Reckitt Benckiser Group Plc - Segment focus
Exhibits 138: Inclusions checklist
Exhibits 139: Exclusions checklist
Exhibits 140: Currency conversion rates for US$
Exhibits 141: Research methodology
Exhibits 142: Validation techniques employed for market sizing
Exhibits 143: Information sources
Exhibits 144: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the probiotic supplements market in Canada: American Biologics LLC, Archer Daniels Midland Co., Biena Inc., BioGaia AB, Biotix Care, Church and Dwight Co. Inc., CUSTOM PROBIOTICS Inc., Genuine Health Inc., International Flavors and Fragrances Inc., Jamieson Wellness Inc., Koninklijke DSM NV, Lallemand Inc., Mars Inc., Natural Factors Nutritional Products Ltd., NOVA Essentials Inc., PetLab Co., Reckitt Benckiser Group Plc, The Clorox Co., The Procter and Gamble Co., and Kerry Group Plc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is intensive research and development in probiotic supplements.'

According to the report, one of the major drivers for this market is the increased awareness about lifestyle-related diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • American Biologics LLC
  • Archer Daniels Midland Co.
  • Biena Inc.
  • BioGaia AB
  • Biotix Care
  • Church and Dwight Co. Inc.
  • CUSTOM PROBIOTICS Inc.
  • Genuine Health Inc.
  • International Flavors and Fragrances Inc.
  • Jamieson Wellness Inc.
  • Koninklijke DSM NV
  • Lallemand Inc.
  • Mars Inc.
  • Natural Factors Nutritional Products Ltd.
  • NOVA Essentials Inc.
  • PetLab Co.
  • Reckitt Benckiser Group Plc
  • The Clorox Co.
  • The Procter and Gamble Co.
  • Kerry Group Plc

Related Topics

Related Reports

Dietary Supplements Market in North America 2024-2028 - Product Image

Dietary Supplements Market in North America 2024-2028

  • Report
  • 133 Pages
  • North America
From
Global Probiotic Ingredients Market 2024-2028 - Product Image

Global Probiotic Ingredients Market 2024-2028

  • Report
  • 165 Pages
  • Global
From
Probiotics Dietary Supplements Global Market Report 2024 - Product Image

Probiotics Dietary Supplements Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
North America Probiotics Market Outlook, 2028 - Product Image

North America Probiotics Market Outlook, 2028

  • Report
  • 103 Pages
  • North America
From
North America Probiotics Market Size, Share & Trends Analysis Report By Ingredient (Bacteria, and Yeast), By Product, By End-use (Human, and Animal), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Image

North America Probiotics Market Size, Share & Trends Analysis Report By Ingredient (Bacteria, and Yeast), By Product, By End-use (Human, and Animal), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 149 Pages
  • North America
From

About the Probiotic Supplement Market

The Probiotic Supplement market is a subset of the larger Vitamins and Dietary Supplements industry. Probiotic supplements are dietary supplements that contain beneficial bacteria or yeasts that are intended to provide health benefits. These supplements are typically taken orally and are available in a variety of forms, including capsules, tablets, powders, and liquids. Probiotic supplements are used to support digestive health, immune system health, and overall wellness. The Vitamins and Dietary Supplements industry is a rapidly growing market, with probiotic supplements being a key component. Consumers are increasingly turning to probiotic supplements to support their health and wellness, and the industry is responding with a wide range of products. Some companies in the Probiotic Supplement market include Nature's Way, Garden of Life, Renew Life, and Culturelle. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.